Search Within

Jenny C Campbell

Formats
  1. Meeting Abstract (6)
  2. Journal Article (3)
Groups
  1. Department of Medicine (9)
  2. Solid Tumor Oncology Division (9)
  3. Center for Pancreatic Cancer Research (7)
  4. Gastrointestinal Oncology Service (7)
  5. Biostatistics Service (6)
  6. Epidemiology and Biostatistics (6)

More Groups

People
  1. David Ilson (7)
  2. David Kelsen (7)
  3. Manish Shah (7)
  4. Yelena Janjigian (6)
  5. Marinela Capanu (5)
  6. Laura Tang (4)

More People

Years
  1. 2019 (1)
  2. 2018 (1)
  3. 2014 (1)
  4. 2012 (3)
  5. 2011 (2)
  6. 2010 (1)
Publications
  1. Journal of Clinical Oncology (5)
  2. American Journal of Clinical Oncology (1)
  3. Cancer (1)
  4. European Journal of Cancer (1)
  5. JAMA Oncology (1)
Publishers
  1. American Society of Clinical Oncology (5)
  2. American Medical Association (1)
  3. Elsevier Inc. (1)
  4. Lippincott Williams & Wilkins (1)
  5. Wiley Blackwell (1)

Results (9)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Use, safety, and efficacy of single-patient use of the US Food and Drug Administration Expanded Access Program
    Journal Article

    Feit, N. Z.; Goldman, D. A.; Smith, E.; Deighan, J.; Iasonos, A.; Zivanovic, O.; Hyman, D. M.
    JAMA Oncology (2019)

    Fulltext@MSK | Save
  • Utilization, safety, and efficacy of the FDA compassionate use program
    Meeting Abstract

    Feit, N.; Smith, E.; Cambria, R.; Anopa, J.; Deighan, J.; Pamer, E.; Wilson, R.; Greenfield, J.; Zivanovic, O.; Hyman, D.
    European Journal of Cancer (2018)

    Fulltext@MSK | Save
  • Phase II trial of cetuximab plus cisplatin and irinotecan in patients with cisplatin and irinotecan-refractory metastatic esophagogastric cancer
    Journal Article

    Janjigian, Y. Y.; Ku, G. Y.; Campbell, J. C.; Shah, M. A.; Capanu, M.; Kelsen, D. P.; Ilson, D. H.
    American Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Phase II trial of bevacizumab, irinotecan, cisplatin, and radiation as preoperative therapy in esophageal adenocarcinoma
    Meeting Abstract

    Ilson, D.; Goodman, K. A.; Janjigian, Y. Y.; Shah, M. A.; Kelsen, D. P.; Rizk, N. P.; Rusch, V. W.; Wu, A. J. C.; Campbell, J.; Capanu, M.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Phase II trial of bevacizumab, irinotecan, cisplatin, and radiation as preoperative therapy in esophageal adenocarcinoma
    Meeting Abstract

    Ilson, D.; Goodman, K. A.; Janjigian, Y. Y.; Shah, M. A.; Kelsen, D. P.; Rizk, N. P.; Rusch, V. W.; Wu, A. J. C.; Campbell, J.; Capanu, M.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Phase 2 trial of induction and concurrent chemoradiotherapy with weekly irinotecan and cisplatin followed by surgery for esophageal cancer
    Journal Article

    Ilson, D. H.; Minsky, B. D.; Ku, G. Y.; Rusch, V.; Rizk, N.; Shah, M.; Kelsen, D. P.; Capanu, M.; Tang, L.; Campbell, J.; more...
    Cancer (2012)

    Fulltext@MSK | Save
  • Phase II trial of sorafenib in esophageal (E) and gastroesophageal junction (GEJ) cancer: Response and protracted stable disease observed in adenocarcinoma
    Meeting Abstract

    Ilson, D.; Janjigian, Y. Y.; Shah, M. A.; Kelsen, D. P.; Tang, L. H.; Campbell, J.; Fuqua, L.; Capanu, M.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Phase II trial of sorafenib in esophageal (E) and gastroesophageal junction (GEJ) cancer: Response observed in adenocarcinoma
    Meeting Abstract

    Ilson, D.; Janjigian, Y. Y.; Shah, M. A.; Tang, L. H.; Kelsen, D. P.; Campbell, J.; Fuqua, L.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Phase II trial of sorafenib in esophageal (E) and gastroesophageal junction (GEJ) cancer: Response observed in adenocarcinoma
    Meeting Abstract

    Ilson, D.; Shah, M. A.; Kelsen, D. P.; Janjigian, Y. Y.; Tang, L. H.; Campbell, J.; Fuqua, L.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save